Chronic diseases: European society guidelines
51 current official documents on chronic diseases from European societies, in PDF. Sources: EULAR (18), KDIGO (12), ESMO (10), ERS (9), ESC (2).
Sign up for our AI library search toolSign up →Chronic diseases in other countries
See also
51 documents
Chronic diseases51
Diabetes2
Respiratory disease16
- ERS/ESGE/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancerEurope · ERS · 2026PDF ↗
- ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease: a multidisciplinary, evidence-based approach to best managementEurope · ERS · 2026PDF ↗
- Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseEurope · ERS · 2025PDF ↗
- ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adultsEurope · ERS · 2024PDF ↗
- “International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343–373.Europe · ERS · 2022PDF ↗
- 2022 ERS guidelines for asthma diagnosis in adultsEurope · ERS · 2022PDF ↗
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyEurope · ESMO · 2021PDF ↗
- ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failureEurope · ERS · 2021PDF ↗
- Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2021PDF ↗
- Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2021PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSEurope · ESMO · 2020PDF ↗
- Recent eUpdate to the ESMO Clinical Practice Guidelines on early and locally advanced non-small-cell lung cancer (NSCLC)Europe · ESMO · 2020PDF ↗
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineEurope · ERS · 2020PDF ↗
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)Europe · ESC · 2019PDF ↗
- “International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague.Eur Respir J2014; 43: 343–373.Europe · ERS · 2018PDF ↗
Kidney disease14
- 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA)Europe · ESC · 2026PDF ↗
- EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 updateEurope · EULAR · 2026PDF ↗
- KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)Europe · KDIGO · 2026PDF ↗
- KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)Europe · KDIGO · 2025PDF ↗
- KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summaryEurope · KDIGO · 2025PDF ↗
- KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Europe · KDIGO · 2025PDF ↗
- KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in ChildrenEurope · KDIGO · 2025PDF ↗
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseEurope · KDIGO · 2024PDF ↗
- KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITISEurope · KDIGO · 2024PDF ↗
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinomaEurope · ESMO · 2021PDF ↗
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseEurope · KDIGO · 2021PDF ↗
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesEurope · KDIGO · 2021PDF ↗
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
Bone, joint and rheumatology18
- EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 updateEurope · EULAR · 2026PDF ↗
- EULAR recommendations for the management of Behçet’s syndrome: 2025 updateEurope · EULAR · 2026PDF ↗
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateEurope · EULAR · 2026PDF ↗
- EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosusEurope · EULAR · 2025PDF ↗
- EULAR recommendations for the treatment of systemic sclerosis: 2023 updateEurope · EULAR · 2025PDF ↗
- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 updateEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosisEurope · EULAR · 2024PDF ↗
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 updateEurope · EULAR · 2024PDF ↗
- KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated VasculitisEurope · KDIGO · 2024PDF ↗
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateEurope · EULAR · 2023PDF ↗
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateEurope · EULAR · 2020PDF ↗
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateEurope · EULAR · 2020PDF ↗
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapiesEurope · EULAR · 2020PDF ↗
- EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritisEurope · EULAR · 2018PDF ↗
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceEurope · EULAR · 2018PDF ↗